Clinical Trials Directory

Trials / Completed

CompletedNCT03408444

Evaluating Soft Contact Lens Prototypes for Myopia Control

Status
Completed
Phase
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Accepted

Summary

This is a multi-site, prospective, randomized, controlled, double-masked, four-arm-parallel-group, dispensing study. Each subject will be bilaterally fitted with one of four types of test articles and wear contact lenses of the assigned lens type during the entire course of the study. Test articles will be worn a minimum 8 hours per day and 5 days per week (subjects will be encouraged to wear study contact lenses 10 hours or more per day and 7 days per week) in a daily disposable modality for a minimum of 6 months and up to 1 year for a total of 7 scheduled visits.

Conditions

Interventions

TypeNameDescription
DEVICEEMO-114Subjects between the ages of 7 and 12 years old will be bilaterally fitted with one of the four types of test articles and wear lenses of the assigned lens type during the entire course of the study.
DEVICEEMO-116Subjects between the ages of 7 and 12 years old will be bilaterally fitted with one of the four types of test articles and wear lenses of the assigned lens type during the entire course of the study.
DEVICEEMO-118Subjects between the ages of 7 and 12 years old will be bilaterally fitted with one of the four types of test articles and wear lenses of the assigned lens type during the entire course of the study.
DEVICEEMO-117Subjects between the ages of 7 and 12 years old will be bilaterally fitted with one of the four types of test articles and wear lenses of the assigned lens type during the entire course of the study.

Timeline

Start date
2017-12-27
Primary completion
2019-05-25
Completion
2019-05-25
First posted
2018-01-24
Last updated
2022-06-08
Results posted
2022-06-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03408444. Inclusion in this directory is not an endorsement.